Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences

Mary E. Velthuizen, Rob B. van der Luijt, Beja J. de Vries, Marco J. Koudijs, Eveline M.A. Bleiker, Margreet G.E.M. Ausems*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology